Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Period	Milestone	Group	Participants
Overall Study	STARTED	1 mg Bid	23
Overall Study	STARTED	3 mg Bid	21
Overall Study	STARTED	10 mg Bid	23
Overall Study	STARTED	30 mg Bid	26
Overall Study	STARTED	3 mg od	22
Overall Study	STARTED	30 mg od	21
Overall Study	STARTED	Placebo	26
Overall Study	COMPLETED	1 mg Bid	18
Overall Study	COMPLETED	3 mg Bid	13
Overall Study	COMPLETED	10 mg Bid	19
Overall Study	COMPLETED	30 mg Bid	13
Overall Study	COMPLETED	3 mg od	18
Overall Study	COMPLETED	30 mg od	12
Overall Study	COMPLETED	Placebo	22
Overall Study	NOT COMPLETED	1 mg Bid	5
Overall Study	NOT COMPLETED	3 mg Bid	8
Overall Study	NOT COMPLETED	10 mg Bid	4
Overall Study	NOT COMPLETED	30 mg Bid	13
Overall Study	NOT COMPLETED	3 mg od	4
Overall Study	NOT COMPLETED	30 mg od	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02081534/flow